Wound Catheter Vs LA Bolus in Renal Transplant: RCT
Sponsored by The Leeds Teaching Hospitals NHS Trust
About this trial
Last updated 2 years ago
Study ID
GS21/138922
Status
Recruiting
Type
Observational
Placebo
No
Accepting
18 to 100 Years
All
Trial Timing
Ended 2 years ago
What is this trial about?
Pain control is an important part of patients' care after a kidney transplant. Currently
patients receive a one off injection of Local Anaesthetic (LA) in the wound at the end of the
operation followed by Intravenous morphine through a Patient Controlled Analgesia System
(PCAS), a button pressed to provide a calculated dose with lock out times for safety.
Through this study the aim to test the efficiency of Continuous Local Anaesthetic
Infiltration via Wound Catheter (LAWC) which is a method to deliver Local Anaesthetic over a
longer period of time after the operation. LAWC are currently in use in a variety of surgical
specialities including Liver surgery. Patients participating in this study will be allocated
randomly to one of 2 groups; one will receive LA at the end of the operation as per current
practice and one will receive LAWC. It then compare outcomes such as the the dose of morphine
required in the PCAS, quality of pain control and improvement in recovery.
What are the participation requirements?
Inclusion Criteria
- Primary kidney transplantation
- Single kidney transplantation
- Signed informed Consent
Exclusion Criteria
- Midline laparotomy
- Dual kidney transplantation
- Kidney re-transplantation
- Multi-organ transplantation
- Patients on Long term opiates
- Patients with psychiatric illness